Innate Pharma S.A. (NASDAQ:IPHA) Q1 2026 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for joining, and welcome to the Innate Pharma First Quarter 2026 Business Update and Financial Results.
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Lion Point Didric Cederholm | 81,151 | $149,318 | 0.71% | |
| 2. | Citadel Investment Group Ken Griffin | 12,441 | $22,891 | 0% | |
| 3. | Millennium Management Israel Englander | 0 | $0 | 0% |
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 43,524 | $80,084 | 0% | |
| 2. | 23,750 | $43,700 | 0.01% | |
| 3. | 15,130 | $27,839 | 0% | |
| 4. | 10,310 | $18,971 | 0% | |
| 5. | 4,719 | $8,681 | 0% |